Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Sarcoma

Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response

Jung Yong Hong, Hee Jin Cho, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Sang Kyum Kim, Yurimi Lee, Yoon-La Choi, Minsuk Kwon, Hyo Song Kim, Jeeyun Lee

Cancer Res Treat. 2023;55(2):671-683. Published online September 27, 2022 DOI: https://doi.org/10.4143/crt.2022.251

Web of Science 3 Crossref 3

Gastrointestinal cancer

Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer

Dagyeong Lee, Junyong Choi, Hye Jeong Oh, In-Hye Ham, Sung Hak Lee, Sachiyo Nomura, Sang-Uk Han, Hoon Hur

Cancer Res Treat. 2023;55(1):167-178. Published online May 20, 2022 DOI: https://doi.org/10.4143/crt.2022.094

Web of Science 3 Crossref 3

Gynecologic cancer

Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers

Joseph J. Noh, Min Kyu Kim, Min Chul Choi, Jeong-Won Lee, Hyun Park, Sang Geun Jung, Won Duk Joo, Seung Hun Song, Chan Lee

Cancer Res Treat. 2022;54(4):1200-1208. Published online December 13, 2021 DOI: https://doi.org/10.4143/crt.2021.828

Web of Science 9 Crossref 8

Gastrointestinal cancer

Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer

Jaewon Hyung, Eun Jeong Cho, Jihun Kim, Jwa Hoon Kim, Jeong Eun Kim, Yong Sang Hong, Tae Won Kim, Chang Ohk Sung, Sun Young Kim

Cancer Res Treat. 2022;54(4):1175-1190. Published online January 12, 2022 DOI: https://doi.org/10.4143/crt.2021.1133

Web of Science 6 Crossref 7

Lung and Thoracic cancer

Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials

Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang

Cancer Res Treat. 2022;54(3):803-816. Published online October 25, 2021 DOI: https://doi.org/10.4143/crt.2021.764

Web of Science 4 Crossref 5

Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer

Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee

Cancer Res Treat. 2022;54(2):458-468. Published online September 10, 2021 DOI: https://doi.org/10.4143/crt.2021.425

Web of Science 6 Crossref 8

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung

Cancer Res Treat. 2022;54(2):424-433. Published online July 7, 2021 DOI: https://doi.org/10.4143/crt.2021.583

Web of Science 10 Crossref 5

General

Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell-Mediated Tumor Therapy

Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang

Cancer Res Treat. 2022;54(2):362-374. Published online August 3, 2021 DOI: https://doi.org/10.4143/crt.2021.424

Web of Science 4 Crossref 4

Rare Cancer

Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center

Young Sok Ji, Se Hoon Park

Cancer Res Treat. 2021;53(3):874-880. Published online December 7, 2020 DOI: https://doi.org/10.4143/crt.2020.1066

Web of Science 8 Crossref 7

Immunotherapy

The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients

Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma

Cancer Res Treat. 2021;53(2):339-354. Published online November 6, 2020 DOI: https://doi.org/10.4143/crt.2020.790

Web of Science 56 Crossref 63

Lung cancer

Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis

Jongheon Jung, Hyae Young Kim, Dong-Gil Kim, Seog Yun Park, A Ra Ko, Ji-Youn Han, Heung Tae Kim, Jin Soo Lee, Youngjoo Lee

Cancer Res Treat. 2021;53(1):77-86. Published online August 6, 2020 DOI: https://doi.org/10.4143/crt.2020.543

Web of Science 8 Crossref 8

Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma

Hae Su Kim, Ji Yun Lee, Sung Hee Lim, Keunchil Park, Jong-Mu Sun, Young Hyeh Ko, Chung-Hwan Baek, Young-ik Son, Han Sin Jeong, Yong Chan Ahn, Min-Young Lee, Mineui Hong, Myung-Ju Ahn

Cancer Res Treat. 2016;48(2):527-536. Published online September 15, 2015 DOI: https://doi.org/10.4143/crt.2015.249

Web of Science 101 Crossref 96